TABLE 3.
Comparison between ZFN, TALEN, CRISPR-Cas, base editors, and prime editors.
ZFN | TALEN | CRISPR-Cas | Base editors | Prime editors |
---|---|---|---|---|
Protein-based genome editing tool comprising DNA cleavage domains fok1 and synthetic zinc finger-based DNA-binding domain | Nuclease-dependent genetic engineering tool that contains the nuclease domain of the fok1 enzyme and TALE protein having customizable DNA-binding repeats | RNA-based genome editing method comprising crRNA, trans-activating CRISPR RNA (tracr RNA), and cas9 enzyme | Newly developed genome engineering tool, classified into C-to-G base editors (CGBEs), cytosine base editors (CBEs), and adenine base editors (ABE), all of which have different compositions | RNA-dependent genome engineering method comprising nCas9 (H840A) and the Moloney murine leukemia virus reverse transcriptase (M-MLV-RT) |
Endonuclease | ||||
fok1 | fok1 | Cas9 | DCas | pegRNA |
NA | NA | Cas protein: Cas9 | Cas protein: nCas9 (D10A) | Cas protein: nCas9(H840A) |
NA | NA | RNA: single guide RNA (sgRNA) | RNA: sgRNA | RNA: prime editing guide RNA (PegRNA) |
NA | NA | Reverse transcriptase: No | Reverse transcriptase: No | Reverse transcriptase: Yes |
Mutation types | ||||
Gene disruption and insertions | Gene disruption and insertions | All types of base insertions, deletions, and substitutions | Transition mutations (no insertion and deletions) | All types of base insertions, deletions, and substitutions |
(CBE) for C:G to T:A transition | ||||
(ABE) for A:T to G:C transition | ||||
(CGBEs) for inducing transversion of C:G into G:C | ||||
Origin | ||||
Artificial gene editing technique | Artificial gene editing technique | Naturally occurring RNA-based bacterial defense mechanism | Engineered nucleases | Engineered nucleases |
Mutation rate | ||||
Moderate | Moderate | Low | High | Very high |
Target recognition efficiency | ||||
High | High | High | Very high | Very high |
Off-target effects | ||||
High | Low | Variable | Very low | Very low |